Kleanthis G. Xanthopoulos, Ph.D.
Managing General Partner
- More than 25 years of experience as a serial entrepreneur in biotechnology
- Founding CEO of Regulus Therapeutics (NASDAQ:RGLS), 2007-2015
- Founder and Director of Senté Inc.
- Managing Director at Enterprise Partners, Venture Capital
- Founding CEO of Anadys Pharma (NASDAQ:ANDS), 2000-2006, acquired by Roche
- E&Y Entrepreneur of the Year, Health Sciences Award Winner, San Diego Region, 2006
- SDBJ Most Admired CEO, Medium Sized Public Company, 2013
- M.Sc. Ph.D. in Molecular Biology from Stockholm University
- Onassis Scholar and Associate Professor of Karolinska Institute, Stockholm, Sweden